Login / Signup

Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.

Andreas SeeberFrancesca BattaglinKai ZimmerFlorian KocherYasmine BacaJoanne XiuGilbert SpizzoVeronica Novotny-DiermayrDietmar RiederAlberto PucciniJeff SwensenMichelle EllisRichard M GoldbergAxel GrotheyAnthony Frank ShieldsJohn L MarshallBenjamin A WeinbergPaul E SacksteinKiat Hon LimGek San TanChadi NabhanWolfgang Michael KornArno AmannZlatko TrajanoskiMartin D BergerEmil LouDominik WolfHeinz-Josef Lenz
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
This is the largest series of RSPOfp/RNF43-mut colorectal cancers reported to date. Comprehensive molecular analyses asserted the unique molecular landscape associated with RSPO/RNF43 and suggested potential alternative strategies to overcome the low clinical impact of Wnt-targeted agents and immunotherapy.
Keyphrases
  • dna damage response
  • stem cells
  • cell proliferation
  • single molecule
  • single cell
  • risk assessment
  • human health
  • climate change